An interesting finding of this analysis was the detection of abrain tumor metastasis, previously undetected by 18F-FDG-PET, aswell as the identification of a HER2-negative tumor metastasis in a patientwith a positive HER2 status of the primary breast tumor. This evidence concerns the gene ERBB2 and breast neoplasm.